skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Would you recommend to buy, hold, or sell GSK?

I ask on behalf of a relative I help with investing. GSK is currently 1.3% of their portfolio. I had already been thinking of recommending that they sell when the news on June 3 came out:

"Shares of GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker."

They are at a 15% loss with their GSK holding (less if you consider dividends), but luckily it is a small part of the portfolio.

I am leaning toward a 'sell recommendation' but am open to counter arguments.

Thanks so much!
Read Answer Asked by Robert on June 18, 2024
Q: I have some money in my RRSP and would like to buy some US stocks. Could you recommend your top picks you think are priced to buy now, which gives 3% or more dividend. Also any you would wait on, and what price point you would enter. Thanks so much!
Read Answer Asked by Pat on April 21, 2022
Q: Hi
In a past question I was provided these US stocks to purchase: VZ, DUK, GILD, ABBV, O. I was looking for: low to moderate risk and high dividend yields I am again looking for another 5 to 7 stocks with similar criterion. As I am trying to build a US portfolio, please provide some diversification suggestions as well. Thanks, Len
Read Answer Asked by Leonard on April 05, 2022
Q: Regarding Ivan's Mar. 28 question about these ADR's: They are all UK domiciled corporations, and the UK has no tax on dividends. Therefore there is no dividend withholding tax, even in a non-registered account. This is one of the reasons I prefer to hold ADR's of UK-headquartered stocks for foreign content - I currently can't make use of the foreign tax credit. (BTI is another one.)
Read Answer Asked by chris on March 29, 2022
Q: Hi Peter & 5i, The above ADR's trade on US Exchanges among others,
whose dividends are passed on to Canadian investors without the dreadful withholding tax, even in taxable accounts. How would you rate them from good to not so good. Also your input on these and others that you can think of, would be appreciated. As always thanks for the great service. Ivan
Read Answer Asked by Ivan on March 28, 2022
Q: Of the big blue chip pharma companies, which are your favourite that you would buy now? Please include others if you prefer others.
Read Answer Asked by Doug on November 02, 2021
Q: As a new subscriber, I’m thoroughly impressed with your advice and 5i Research services overall - thank you for all that you do.

I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?
Read Answer Asked by Anthony on October 12, 2021
Q: Hello!
1) I would like to get a good, general US healthcare etf .. what might you recommend now? (Long term income investor)

2) also, I would like an etf that has companies like Sanofi and GSK, at decent weights .. what do you think? I see that VYMI has them but at very low percentages.

Appreciate your advice. Thank you!
Read Answer Asked by Patrik on April 21, 2020
Q: Hi Team
For my spouse’s RRSP
Between Glaxosmithkline (GSK) and Bayer AG (BAYRY) which is the better investment to accompany Royal Phillips NV. (PHG)
Within a household is it ok to own similar securities between partners and accounts or is it more prudent to hold different companies for maximum diversification and some downturn protection. I own JNJ, NVO and GUD.
Thank-you in advance, Sam
Read Answer Asked by sam on January 16, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!